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“What’s in a name?” Shakespeare famously wrote. During our
recent experience in conceptualizing and creating a new Office of
Translational Biomedicine at the NIEHS, we have learned that the
answer, often, is “quite a lot,” and perhaps necessarily so. The prob-
lem in this instance arises from the use of the term “translational.”
This term has come to represent an area of biomedical research that,
although full of promise, defies easy definition. Although variations
of “translational medicine” and “translational research” are widely
used to identify scientific programs in both public and private orga-
nizations, when asked what the term means, even many would-be
practitioners might respond with some version of the “I know it
when I see it” explanation. But it may be broadly described as using
knowledge gained at the bench of basic research—a mechanistic
understanding of disease—to improve clinical applications at the
“bedside” or enhance disease prevention in the community. Our
initial view was that the use of the term “translational” to describe
this area of biomedical research is misleading, as the word carries
many connotations, and is essentially inaccurate. However, this view
is debatable. 
The Encarta World English Dictionary defines translation as
“the rendering of something written or spoken in one language in
words of a different language.” The part of this definition that
applies to the concept of translational biomedicine is the idea of dif-
ferent languages. Most basic researchers, clinical investigators, and
public health scientists would agree that they speak essentially differ-
ent “languages” when it comes to understanding and communicat-
ing the science of their respective fields. According to the NIH
Roadmap for Medical Research, this communication gap is “limit-
ing professional interest in the field and hampering the clinical
research enterprise at a time when it should be expanding.” Perhaps
nowhere is this more evident than in the disjunction between basic
environmental health science research and the application of this
knowledge to disease prevention, pathogenesis, and prognosis.
While the reasons behind this are myriad, one of the current chal-
lenges for the NIEHS is to find a way to bridge this gap. This
represents the fundamental challenge and opportunity of our new
Office of Translational Biomedicine (whose name may yet
change), which is now headed by William J. Martin II, a physi-
cian-scientist and former dean of the College of Medicine at the
University of Cincinnati. 
NIEHS scientists have contributed much toward under-
standing basic biology, genotoxicity, endocrine disruption, cell
signaling, and oxidative stress, as well as to public health through
understanding of morbidity and mortality of air pollution.
Notable examples include elucidation of the effects of lead on IQ
and the links between arsenic and cancer. While we will continue
to strategically support these areas of investigation, we believe
that we need to aggressively pursue new opportunities in transla-
tional biomedical research that simply were not available even a
decade ago. 
With the sequencing of the human genome, as well as the
genomes of many model organisms, and the technological tools
that are now becoming available, investigators can integrate knowl-
edge gained through these advances into epidemiologic studies and
bring fundamental biological approaches to the bedside. An exam-
ple of this is the breakthrough in lymphoma research that now
allows us to classify these diseases into distinct biological categories
that have vastly different prognoses and responses to treatment.
Similarly, investigators used this approach to understand the role of
aflatoxin in the biological changes that lead to the development of
liver cancer. Although this research took more than 30 years to
complete, we can now more rapidly apply similar approaches to
understanding how environmental exposures influence the basic
biology leading to a number of diseases like asthma, reproductive
disorders, atherosclerosis, diabetes, various types of cancer, autoim-
mune diseases, and neurodegenerative conditions. This requires
basic scientists, clinical investigators, and public health scientists to
find a new common language for describing disease mechanisms in
order to improve human health. This is our opportunity and our
responsibility.
These efforts will be facilitated through the development of
research initiatives that utilize and emphasize integration of basic,
clinical, and public health sciences, development of interdiscipli-
nary training programs, incorporation of a human disease–first
approach to traditional environmental health sciences, and foster-
ing of relationships among scientists of different disciplines to
develop the research teams of tomorrow that will clearly delineate
the central role of exposures in the pathogenesis of complex
human diseases. If we are successful in these efforts, and we
believe we will be, then the ultimate improvements in human
health, by whatever name, will be a significant achievement. 
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[Translational biomedicine] requires basic scientists,
clinical investigators, and public health scientists to find
a new common language.
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